SSY Group (02005.HK): Trustee Acquires 1 Million Shares Under Restricted Share Incentive Scheme
NewTimeSpace News: On June 24, 2026,SSY Group(02005.HK) issued an announcement stating that under the restricted share incentive scheme adopted by the company on 27 December 2018, the scheme trustee acquired an aggregate of 1,000,000 company shares on the open market on June 24, 2026, funded by the company’s internal resources. Such shares will be held in trust for selected participants.
As disclosed in the announcement, the newly purchased shares account for approximately 0.034% of the total issued shares as at present. The average consideration per share stands at around HK$2.1930 (excluding expenses), with a total purchase consideration of roughly HK$2,193,000.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- SSY GROUP (02005.HK): Four Products Receive NMPA Drug Manufacturing Registration Approvals, Deepening Infusion Therapy and Ophthalmology Portfolio
- SSY Group (02005.HK): All 16 Specifications of 13 Pharmaceutical Varieties Proposed to Be Selected in the 12th National Centralized Drug Procurement
- SSY Group (02005.HK): Cimetidine Injection and Acetylcysteine Solution for Inhalation Obtain Manufacturing Registration Approvals
- SSY GROUP (02005.HK): Four Products Obtain NMPA Manufacturing Registration Approvals, All Deemed to Have Passed Consistency Evaluation
- SSY GROUP (02005.HK): Gadobutrol API Approved for Registration by NMPA, a New-Generation Macrocyclic MRI Contrast Agent
